ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,713.64
      1.70%
      US Tech 100
      19,296.40
      -0.20%
      Dow Jones
      42,025.19
      1.26%
      Brent Oil
      74.18
      -0.19%
      Bitcoin
      63,440.94
      0.78%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ultragenyx Pharmaceutical Inc (RARE)

      7. Ultragenyx Pharmaceutical Inc (RARE) Financials

      Ultragenyx Pharmaceutical Inc

      Ultragenyx Pharmaceutical Inc (RARE)

      Energ Trns Mtl Rare UCITS ETF
      Tactical Resources Corp
      Wt Etmtl & Rare
      WisdomTree Issuer ICAV
      Tactical Resources Corp
      WisdomTree Issuer ICAV
      58.78
      1.08
      (1.87%)
      Closed September 19 4:00PM
      Delayed by 15 minutes
      58.78
      0.00
      ( 0.00% )
      Pre Market: 4:05AM
      Delayed by 15 minutes

      Ultragenyx Pharmaceutical Inc Financial Summary

      The current RARE market cap is 5.42B. The company's latest EPS is USD -6.5821 and P/E is -8.93.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 108.31M98.05M127.39M108.83M147.03M
      Operating Income -147.96M-145.1M-122.05M-165.35M-116.36M
      Net Income -159.83M-159.65M-123.19M-170.68M-131.6M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 103.71M271.03M351.41M363.33M434.25M
      Operating Income -424.17M-330.12M-381.74M-648.92M-569.21M
      Net Income -402.73M-186.57M-454.03M-707.42M-606.64M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.31B1.24B1.49B1.31B1.62B
      Total Liabilities 1.18B1.21B1.22B1.17B1.19B
      Total Equity 129.03M31.71M275.41M140.26M432.42M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.14B1.76B1.52B1.55B1.49B
      Total Liabilities 481.73M605.18M599.84M1.19B1.22B
      Total Equity 653.76M1.15B922.56M352.49M275.41M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -273.03M-390.9M-474.81M-190.73M-267.69M
      Investing 210.72M275.02M168M94.44M155M
      Financing 32.3M57.53M388.14M-58k384.88M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -345.38M-132.22M-338.71M-380.47M-474.81M
      Investing -13.04M-179.12M-195.37M-291.65M168M
      Financing 679.31M600.27M118.55M501.21M388.14M

      Stats and Ratios

      Market Cap 5.42B
      Price to Earnings Ratio -8.93
      Price to Sales Ratio 12.48
      Price to Cash Ratio 25.36
      Price to Book Ratio 19.67
      Dividend Yield -

      Share Statistics

      Shares Outstanding 92.17M
      Average Volume (1 week) 659.29k
      Average Volume (1 Month) 599.77k
      52 Week Change 61.66%
      52 Week High 60.37
      52 Week Low 31.52
      Spread (Intraday) 38.46 (41.15%)

      Company Info

      Company Name Ultragenyx Pharmaceutical Inc
      Address corporation trust center
      wilmington, delaware 19801
      Website https://www.ultragenyx.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      RARE
      Ultragenyx Pharmaceutical
      Delayed Upgrade Clock